Compare S&P500 ETF (SPY) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
S&P500 ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? S&P500 ETF trades at $767.25 (market cap $821.11B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: S&P500 ETF is far larger — about 456.2× Vir Biotechnology Inc. Common Stock's market cap, and S&P500 ETF is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold S&P500 ETF for 206 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SPY | VIR | |
|---|---|---|
Market Cap | $821.11B | $1.80B |
Volume | 25,825,560 | 1,782,836 |
52-Week High | $779.14 | $11.78 |
52-Week Low | $631.99 | $5.12 |
Typical Hold Time | 206 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $1.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPY (SPDR S&P 500 ETF Trust) trades at $778.05, showing minimal daily movement with a slight decline of -0.02 (-0.0%). Technical indicators signal a bullish trend with strong moving average support, though oscillators remain neutral. The ETF maintains its position as the primary S&P 500 tracking fund with upcoming dividend distribution scheduled for October 2026.
The ETF's outlook remains tied to broader market performance with Wall Street monitoring earnings growth projections. Key risks include potential profit growth slowdown from 35% to 15% in 2027 and elevated market valuations. Current technical strength suggests near-term stability, but macroeconomic factors could drive volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About S&P500 ETF
The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
